Package 0338-0008-01

{"route": ["INTRAVENOUS"], "spl_id": "67f5816c-3188-40f9-9a8f-97e92a26ff73", "openfda": {"unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["3ed3e0a9-a0a8-4555-9f73-2043e79e3398"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0338-0008-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0338-0008-01", "marketing_start_date": "20190905"}], "brand_name": "Fosaprepitant", "product_id": "0338-0008_67f5816c-3188-40f9-9a8f-97e92a26ff73", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0338-0008", "generic_name": "Fosaprepitant Dimeglumine", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA211860", "marketing_category": "ANDA", "marketing_start_date": "20190905", "listing_expiration_date": "20271231"}